Emkay Global Financial Services maintains its ‘Buy’ rating on Park Medi World, raising the target price to ₹375 following strong June quarter results, with revenue growth of 19% YoY and profit after tax increasing by 31%. Capacity expands amid risks in government collections.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.